Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-97.95%
operating margin TTM
-65.76%
revenue TTM
6.02 Million
revenue per share TTM
4.41$
valuation ratios | |
|---|---|
| pe ratio | -0.47 |
| peg ratio | -0.01 |
| price to book ratio | 0.44 |
| price to sales ratio | 0.46 |
| enterprise value multiple | -0.86 |
| price fair value | 0.44 |
profitability ratios | |
|---|---|
| gross profit margin | 37.81% |
| operating profit margin | -65.76% |
| pretax profit margin | -97.27% |
| net profit margin | -97.95% |
| return on assets | -59.03% |
| return on equity | -80.74% |
| return on capital employed | -54.01% |
liquidity ratios | |
|---|---|
| current ratio | 3.67 |
| quick ratio | 3.03 |
| cash ratio | 0.49 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 165.31 |
| operating cycle | 223.95 |
| days of payables outstanding | 228.62 |
| cash conversion cycle | -4.68 |
| receivables turnover | 6.23 |
| payables turnover | 1.60 |
| inventory turnover | 2.21 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.45 |
| cash per share | 4.30 |
| operating cash flow per share | -4.45 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Arcadia Biosciences, Inc. (NASDAQ:RKDA) reported earnings?
Arcadia Biosciences, Inc. (RKDA) published its most recent earnings results on 07-11-2025.
What is Arcadia Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Arcadia Biosciences, Inc. (NASDAQ:RKDA)'s trailing twelve months ROE is -80.74%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Arcadia Biosciences, Inc. (RKDA) currently has a ROA of -59.03%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RKDA's net profit margin stand at?
RKDA reported a profit margin of -97.95% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RKDA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.67 in the most recent quarter. The quick ratio stood at 3.03, with a Debt/Eq ratio of 0.00.